Trial Profile
A Phase 3B Open-Label Follow-on Trial to Assess the Continued Safety of and Adherence to a Vaginal Ring Containing Dapivirine in Women
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Sep 2023
Price :
$35
*
At a glance
- Drugs Dapivirine (Primary)
- Indications HIV infections
- Focus Adverse reactions; Therapeutic Use
- Acronyms HOPE
- 20 Sep 2023 Results (n=38) assessing HIV Drug Resistance Assessment among Women who Seroconverted during the this study published in the JAIDS
- 19 Oct 2022 Results of sub analysis assessing insight on disclosure and male partner influence on ring acceptability published in the JAIDS published in the JAIDS
- 03 Dec 2020 Results published in the JAIDS